Sunday, October 31, 2021

Urology Devices Market worth $46.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026", published by MarketsandMarkets™, the market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1%.

Browse in-depth TOC on "Urology Devices Market"

122 – Tables
36 – Figures
198 – Pages

Download PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212

The rising incidence and prevalence of urological conditions drives growth in the urology devices market, growing preference for minimally invasive procedures, and the growing number of hospitals and investments in endoscopy and laparoscopy facilities are among the other factors. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the market.

The instruments segment accounted for the largest share of the urology devices market, by product segment, in 2020

Based on product, the market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the market in 2020. This segment includes dialysis devices, endoscopes, laser and lithotripsy devices, robotic systems, endovision and imaging systems, insufflators, endoscopy fluid management systems, and urodynamic systems. The dialysis devices segment accounted for the largest share of the urology instruments market in 2020. The large share of this segment can be attributed to the growing patient pool of CKD due to the rising geriatric population.

Urological cancer and BPH segment to register the highest growth rate during the forecast period

The urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications based on application. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. This can be attributed to the rising incidence of urological cancers coupled with the growing number of cancer-related surgeries.

The hospitals, ASCs, and clinics segment accounted for the largest share of the urology devices market, by end user segment, in 2020

Based on end users, the market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the hospitals, ASCs, and clinics segment accounted for the largest share of the market. The improving healthcare infrastructure in developing countries such as India, the rising number of target procedures, and the rising number of surgeries are the major factors driving this segments growth.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=173062212

North America is the largest regional market for urology devices market

the market is segmented into five regions, namely, North AmericaEuropeAsia PacificLatin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the urology devices market. The large share of this region can be attributed to the increasing healthcare expenditure, highly developed healthcare systems in the US and Canada, and increasing prevalence of chronic and lifestyle conditions.

The major players operating in this urology devices market are  Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India).

Browse Related Reports:

Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/urinary-catheter-market-132934629.html

 

 

Friday, October 29, 2021

Hemodialysis and Peritoneal Dialysis Market worth $105.1 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Tube, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (Conventional, CAPD, Nocturnal), User (Hospital, Home Care, ASCs) - Global Forecasts to 2026", published by MarketsandMarkets™, the global Hemodialysis Dialysis Market is projected to reach USD 105.1 billion by 2026 from USD 76.9 billion in 2021, at a CAGR of 6.4% during the forecast period.

Browse in-depth TOC on "Hemodialysis and Peritoneal Dialysis Market"

440 – Tables
48 – Figures
338 – Pages

Download PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279

The increasing incidence of chronic kidney disease, the availability of advanced dialysis, machines disposables and replacement fluids, and increasing government initiatives to increase the accessibility of dialysis treatment and growing adoption home hemodialysis are expected to drive market growth in the coming years

The hemodialysis and peritoneal dialysis market include major Tier I and II suppliers of HD & PD products & services are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaverum (Germany), Medtronic plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife SA (Switzerland), and Isopure Corp. (USThese suppliers have their manufacturing facilities spread across regions such as North America and Europe.

COVID-19 has impacted their businesses as well. The surge in the number of COVID cases, along with the rise in its severity rate, is likely to create a potential increase in the incidence of kidney damage. Due to the pandemic, the demand for renal replacement fluids has increased significantly worldwide. The demand for RRT among patients with COVID-19 has increased fivefold compared to the historical US populations (4.9% as of 2020 VS. 0.9% earlier) (Source: American Society of Nephrology, 2021). The gradual shift towards home hemodialysis treatment before the pandemic and the concerns over the spread of COVID-19 infection have considerably accelerated patient interest in HD treatment. This factor is likely to boost the adoption of home hemodialysis products during the epidemic.

The rise in number of dialysis service provider to support the market growth during the forecast period."

Significant rise in number of dialysis service provider, coupled with the growing prevalence of ESRD. Along with this growing focus of dialysis service providers towards expansion of their services offerings by launching and acquiring new dialysis centers across the globe is likely to contribute towards the growth of the segment.

Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279

Asia Pacific likely to emerge as the fastest-growing hemodialysis and peritoneal dialysis market, globally

Geographically, the emerging Asian countries, such as ChinaIndiaJapan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 8.8% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with acute kidney disease, diabetes, hypertension are factors likely to support the growth of hemodialysis and peritoneal dialysis market in the region. Moreover, initiative by government to increase the accessibility of the dialysis treatment in the region are likely to offer huge opportunity for the players to capture large customer base.

Prominent players in this Hemodialysis Market are Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), among others

Browse Related Reports:

China Hemodialysis and Peritoneal Dialysis Market by Product & Services (HD, PD, Machine, Dialyzer, Concentrate, Dialysate, Catheter, Service), Modality (CAPD, APD, Nocturnal), End User (Hospital, Independent Center, Home Dialysis) - Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/china-hemodialysis-peritoneal-dialysis-market-150472097.html

Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026

https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html

 

 

Chromatography Instruments Market worth $11.0 billion by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report " Chromatography Instruments Market  by Type (Liquid Chromatography, Gas Chromatography), Consumable & Accessory (Columns, Detectors, Pressure Regulators), End User (Life Science Industry, Oil & Gas Industry), and Region - Analysis & Global Forecasts to 2025", published by MarketsandMarkets™, the Chromatography Instruments Market is expected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020, at a CAGR of 5.1%.

Browse in-depth TOC on "Chromatography Instruments Market"
141 – Tables
33 – Figures
248 – Pages

Download PDF Brochure: -  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1258

The growing investments in the pharmaceutical R&D, rising food safety concerns, increasing adoption of gas chromatography in oil & gas industry and policies to reduce environmental pollution levels are the key drivers of the chromatography instruments market growth. Increasing burden on healthcare systems owing to the COVID-19 pandemic worldwide and growing importance of chromatography tests in drug approval process will further upsurge the demand for chromatography instruments.

The chromatography instruments market includes Tier I and II vendors like Agilent Technologies, Shimadzu Corporation, Waters Corporation, Thermo Fisher Scientific and PerkinElmer among others. The companies have a large market spread across various countries in North AmericaEuropeAsia Pacific and Rest of the World. The global COVID-19 outbreak has impacted the business to a certain extent as multiple manufacturing facilities of players were shut down during the lockdown. Despite of the challenging situation, industries are gradually recovering from the impact of the pandemic. As the supply and distribution channels are beginning to open up, business operations are likely to rise at a slow and steady rate in the near future. Thus, the pandemic is not estimated to have long-term effects on the fundamental growth drivers of the chromatography instruments market. It is estimated that market reconciliation and development would be seen toward the beginning of 2021.

Liquid chromatography systems segment is anticipated to be the fastest growing segment during the forecast period

The market is segmented by type, into liquid chromatography (LC) systems, gas chromatography (GC) systems, supercritical fluid chromatography (SFC) systems and thin-layer chromatography (TLC) systems.. The liquid chromatography systems segment is estimated to command the largest share of the market in 2020, and is projected to register the highest CAGR during the forecast period. Increasing demand for liquid chromatography systems in pharma and biotech industries along with growing adoption of gas chromtaogrpahy systems in oil & gas industries is expected to boost the market growth during the forecast period.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1258

Columns, that form the most important part of the chromatography systems, are expected to command the largest market share in 2020

The chromatography instruments market, by consumable & accessory is broadly segmented into column, column accessories, autosampler, autosampler accessories, flow management accessories, solvents/reagents/adsorbents, chromatography fittings and tubing, detectors, mobile phase accessories, fraction collectors, pressure regulators, and other accessories. The columns segment is expected to occupy large market share owing to the importance of columns in the chromatography systems, as chromatographic separation takes place inside the column. Additionally, growing importance of chromatography tests in drug development, will subsequently upsurge the demand for such chromatography consumables and accessories.

Life science industry to witness highest growth during the forecast period

The end-user industry is segmented into life science industry, academic & research institutes, oil & gas industry, environmental agencies, food & beverage industry and other end user industries. The life science industry is expected to hold the largest share of the market in 2020 owing to the increasing R&D investment by pharmaceutical & biotechnology companies. This end-user segment is expected to grow rapidly in the coming years due to the use of chromatography in various research applications, bulk drug manufacturing, stabilization of drugs, and qualitative and quantitative pharmaceutical analysis.

The North America chromatography instruments market to hold the largest market share in 2020

North America is expected to dominate the global market in 2020, followed by Europe, whereas the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high regional growth is attributed to the increasing R&D funding in healthcare industries, growing number of preclinical activities by CROs and pharmaceutical companies, upsurge in the number of metabolomics research studies, growing food and agricultural industry in Canada and presence of developed healthcare and research infrastructure.

The major players operating in the chromatography instruments market include Agilent Technologies (US), Waters Corporation (US), Shimadzu (Japan), Thermo Fisher Scientific (US), PerkinElmer (US), Merck KGaA (Germany), Phenomenex (US), Bio-Rad Laboratories (US), Cytiva (US), Hitachi (Japan) and Restek Corporation (US) among others.

Browse Related Reports:

High-performance Liquid Chromatography (HPLC) Market by Product (Instruments (Systems, Detectors), Consumables (Columns, Filters), and Accessories), Application (Clinical Research, Diagnostics, Forensics), Region - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/hplc-market-117899209.html

 

Thursday, October 28, 2021

Ophthalmic Equipment Market worth $63.3 Billion by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Ophthalmic Equipment Market by Product (OCT, Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Excimer Laser, OVDs, Phacoemulsification) End User (Hospital, Consumer) - Global Forecast to 2025", published by MarketsandMarkets™, the market size is projected to reach USD 63.3 billion by 2025 from USD 52.8 billion in 2020, at a CAGR of 3.7% during the forecast period. The rapid growth in the geriatric population, rising prevalence of eye diseases, and technological advancements in ophthalmic devices are the major factors driving the growth of this market.

Browse and in-depth TOC on "Ophthalmic Equipment Market"

391 - Tables

41 - Figures

372 - Pages

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

The vision care products segment is expected for the largest share of the Ophthalmic Equipment Market in 2019.

Based on product, the Ophthalmic Equipment Market is categorized mainly into diagnostic & monitoring devices, surgical devices, and vision care products. In 2019, the vision care products segment was expected to account for the largest share of the Ophthalmic Equipment Market. The large share of this segment can primarily be attributed to the high prevalence of eye disorders such as myopia, hyperopia, astigmatism, and presbyopia. In addition to this, technological advancements in lens materials, growing awareness about eyesight correction, and rising trends in eyewear, such as styled sunglasses and advanced contact lenses boasting extra comfort, have further stimulated the adoption of vision care products.

By end user, the specialty clinics & ambulatory surgery centers (ASCs) segment is expected to grow at the highest CAGR during the forecast period.

Based on end-user, the Ophthalmic Equipment Market is segmented into consumers, hospitals, specialty clinics & ambulatory surgery centers (ASCs), and other end users. specialty clinics & ambulatory surgery centers (ASCs) are expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the rising number of cataract surgeries performed in these facilities due to their cost-effectiveness.

Get 10% Customization Research Report: -https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155637364

North America to hold the largest regional market share in 2019.

North America is expected to account for the largest share of the Ophthalmic Equipment Market in 2019, followed by Europe. The large share of North America can be attributed to the rising prevalence of ocular disorders, growth in the geriatric population, increase in healthcare expenditure, and technological advancements in ophthalmic equipment. In addition, factor such as the growing awareness and uptake of ophthalmic treatments and surgeries and the availability of advanced ophthalmic devices in this region are also driving the growth of the Ophthalmic Equipment Market in North America.

The prominent players in Ophthalmic Equipment Market are EssilorLuxottica (France), Alcon (US), Johnson & Johnson Vision Care (US), HOYA Corporation (Japan), Bausch + Lomb (US), Carl Zeiss Meditec (Germany), Topcon (Japan), Glaukos Corporation (US), Haag-Streit (Switzerland), NIDEK (Japan), STAAR Surgical (US), Ziemer Ophthalmic Systems (Switzerland), CooperVision, Inc. (US), Oculentis (Germany), Heidelberg Engineering (Germany), Canon (Japan), Optovue (US), Neo Vision (Korea), Lumenis (Israel), Reichert Technologies (US), OPHTEC BV (Netherlands), Heine Optotechnik (Germany), and Luneau Technology (France).

Browse Related Reports:

Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022

https://www.marketsandmarkets.com/Market-Reports/ophthalmic-surgical-instrument-market-11819932.html

Ophthalmic Lasers Market by Product Type (Femtosecond Lasers, Excimer Lasers, Nd:YAG Lasers, Diode Lasers, and Other Lasers), Application (Refractive Error Correction, Cataract Removal, Glaucoma Treatment, Diabetic Retinopathy Treatment, AMD Treatment, and Other Applications), & End User (Hospitals and Clinics and Ambulatory Surgery Centers (ASCs) - Global Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/ophthalmic-laser-market-251971654.html

 

 

 

The outbreak of the COVID-19 pandemic and growing prevalence of respiratory diseases to propel growth of the ventilators market by 2021 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hospital, Home Care, ACC, Emergency Medical Services) Covid-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the market is driven by the outbreak of the covid-19 pandemic, high prevalence of respiratory diseases, rapid growth in the geriatric population, increasing number of preterm births, and the rising number of ICU beds. However, factors such as dearth of skilled medical workers, reimbursement concerns, complications associated with the use of ventilators, reluctance among physicians for the adoption of new technologies are expected to restrain the growth of this market to a certain extent during the forecast period.

Browse in-depth TOC on "Ventilator Market"
190 – Tables
57 – Figures
250 – Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337

By mobility, the intensive care segment to witness the highest growth in the market

Based on mobility, the market for ventilators is segmented into intensive care ventilators and portable/transportable ventilators. The intensive care ventilators segmented is estimated to be USD 5.5 billion in 2020. It is expected to grow at AGR of 535.4% from 2019 to 2020.The intensive care ventilators segment is projected to witness the highest growth in the market during the forecast period. Growth in this segment is attributed due to the rising number of intensive care beds equipped with ventilators. The increasing ICU admission due to COVID-19 and readmissions in developed countries coupled with appropriate reimbursement is also responsible for the growth of the ICU ventilators segment. The ICU ventilators segment is further sub-segmented into high-end ICU ventilators, mid-end ICU ventilators, and basic ICU ventilators.

On the basis of type, the adult/pediatric ventilators segment is expected to account for the largest share of the ventilators market in 2019

Based on type, the market for ventilators is segmented into adult/pediatric ventilators and neonatal/infant ventilators. The adult/pediatric ventilators segment accounted for the largest share of the market in 2019. The large share of this segment is largely driven by the large adult population suffering from COVID-19, chronic diseases such as COPD & asthma, the high prevalence of smoking, and the rising geriatric population.

By interface, the invasive ventilation segment to witness the highest growth in the ventilators market

Based on the interface, the market for ventilators is segmented into invasive ventilation and non-invasive ventilation segment. The invasive ventilation segment is projected to witness the highest growth in the intensive care ventilator market during the forecast period. Growth in the invasive ventilation market can be attributed to increasing severity in COVID-19 patients and the rising prevalence of respiratory diseases, neurological diseases, and sleeping disorders.

On the basis of mode, the combined-mode ventilation segment is expected to account for the largest share of the ventilator market in 2019

Based on the mode of ventilation, the market is segmented into volume-mode ventilation, pressure-mode ventilation, combined-mode ventilation, and other modes. The combined-mode ventilation segment accounted for the largest share of the market. The large share of the segment is attributed to its advantages over conventional pressure-mode ventilation and volume-mode ventilation. The ability of combined-mode ventilation to provide both modes of ventilation makes it a desirable product in the market.

By end-user, the emergency medical services segment to witness the highest growth in the ventilators market

On the basis of end-user, the ventilator market is segmented into hospitals and clinics, home care, ambulatory care center, and emergency medical services. The emergency medical services segment is projected to witness the highest growth in the market during the forecast period. Growth in this segment is attributed to the high incidence of trauma injuries, such as road accidents and falls, sports injuries, and criminal injuries.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:  -    https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=11018337

North America to dominate the ventilator market during the forecast period

North America is expected to account for the largest share of the market in 2019, followed by Europe. The dominance of the North American region can be attributed to the rising geriatric population, high prevalence of smoking, high prevalence of respiratory diseases, increasing COVID-19 patient volume, highly developed healthcare system, high healthcare expenditure, and major market players in the US.

The prominent players in the intensive care ventilators market are Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK), Allied Healthcare Products, Inc. (US).

In-Vitro Diagnostics Market worth $96.0 billion by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025", published by MarketsandMarkets™, the global IVD Market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period.

Browse in-depth TOC on "In-Vitro Diagnostics Market"
262 – Tables
53 – Figures
359 – Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703

Factors such as the increased adoption of PoC IVD devices, rising elderly population base, and the growing number of infectious diseases are expected to drive the growth of the IVD Market.

By-products and services, the reagents & kits segment is expected to dominate the in vitro diagnostics market in 2020

Based on products and services, the IVD Market has been segmented into regents and kits, instruments, data management software and services. Within market, reagents and kits accounted for the largest share in 2020. The large share of this segment can be attributed to the superior quality of reagents enabling accurate diagnosis and thus, having high preference amongst the healthcare professionals.

By end user, a point-of-care testing segment is expected to grow at the highest CAGR in the in vitro diagnostics market during the forecast period

Based on end user, the market has been segmented into hospitals, laboratories, patient self-testing, academia, point-of-care -testing others. The point-of-care testing segment is estimated to have enormous growth due to rising availability of highly efficient PoC kits. Recently launched point-of-care devices offer a precise diagnosis of chronic diseases that has raised its adoption in laboratories.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: -https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=703

North America holds the largest share in the market in 2020, followed by Europe

North America dominates the overall IVD Market based on region. This can be attributed to the rising geriatric population. Elderly population has comparatively weaker immunity and, therefore, is more susceptible to infections and other diseases. Furthermore, the regulatory scenario is quite stringent in the region that ensures the availability of defect-free IVD devices in the market that proves beneficial for market growth.

The prominent players in the in vitro diagnostics market include Roche Diagnostics Limited (
Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), Diasorin (Italy), Ortho-Clinical Diagnostics (US), and Qiagen (Germany).

Browse Related Reports:

US In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020

https://www.marketsandmarkets.com/Market-Reports/u-s-in-vitro-diagnostics-market-66290979.html

 

Breast Biopsy Devices: Empowering Early Detection and Treatment

  The major factors driving the growth of Breast Biopsy Devices Market include the growing prevalent cases of breast cancer, the increasing ...